Gene-drug interactions (data source: DGIdb)
Gene Name Entrez ID Drug Name Chembl ID Interaction Types Sources publications
ABCA1 19 CERIVASTATIN CHEMBL1477 PharmGKB
ABCA1 19 PROBUCOL CHEMBL608 inhibitor GuideToPharmacologyInteractions, ChemblInteractions, DrugBank 19427182, 19075491, 19458386, 20075420, 1868500, 15514211
ABCA1 19 CYCLOSPORINE CHEMBL160 NCI 15084924
ABCA1 19 DORZOLAMIDE CHEMBL218490 GuideToPharmacologyInteractions
ABCA1 19 ADENOSINE TRIPHOSPHATE CHEMBL14249 DrugBank 17224860, 17135600, 16858612
ABCA1 19 GLYBURIDE CHEMBL472 inhibitor DrugBank 15905177, 14660039, 19805629, 12426219, 15039140, 15102890

Variant-drug associations (data source: PharmGKB)
Gene Name Variant Alleles Chemical Phenotype Category Significance Notes Sentence Publications Annotation ID
ABCA1 rs12003906 C atorvastatin efficacy yes As measured by reduction in LDLc. Association was seen at low and high doses. Association reported for minor allele but base not specified; estimated from dbSNP to be the C allele (on the plus chromosomal strand). Allele C is associated with decreased response to atorvastatin, pravastatin or simvastatin in people with Hyperlipidemias as compared to allele G. 20031551 827807823
ABCA1 rs2230808 CC fenofibrate efficacy yes Patients with the CC genotype had a greater small high-density lipoprotein (HDL) particle concentration (units = umol/L) and a greater total HDL particle concentration after fenofibrate treatment for 3 weeks, as compared to patients with the TT genotype. Genotype CC is associated with increased response to fenofibrate in people with Hypertriglyceridemia as compared to genotype TT. 20346718 982044801
ABCA1 rs2230806 CT fenofibrate efficacy yes Patients with the CT genotype had a greater small high-density lipoprotein (HDL) particle concentration (units = umol/L) after fenofibrate treatment for 3 weeks, as compared to patients with the CC genotype. Genotype CT is associated with increased response to fenofibrate in people with Hypertriglyceridemia as compared to genotype CC. 20346718 982044812
ABCA1 rs2230806 TT fenofibrate efficacy yes Patients with the TT genotype had a greater total high-density lipoprotein (HDL) particle concentration (units = umol/L) after fenofibrate treatment for 3 weeks, as compared to patients with the CC genotype. Genotype TT is associated with increased response to fenofibrate in people with Hypertriglyceridemia as compared to genotype CC. 20346718 982044822
ABCA1 rs2487032 A clopidogrel metabolism/PK yes This variant was associated increased the concentration of plasma clopidogrel’s active metabolite H4 and increased inhibition of platelet function. However, it was not associated with clinical outcome of clopidogrel. Allele A is associated with increased metabolism of clopidogrel as compared to genotype GG. 27981573 1448624896